Chongqing, China

Lei Ye

This inventor holds 23 USPTO granted patents and 10 published patent applications and 19 EPO patents, primarily in Porous Materials. Top assignees: Chongqing Runze Pharmaceutical Company Limited, Chongqing Ruzer Pharmaceutical Company Limited, Chongqing Runze Pharmaceuticals Co., Ltd.. Active years: 2014-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lei Ye. Retrieved from https://idiyas.com/inventor/lei-ye

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23 

% Patents Active = 47.8

 

Average Co-Inventor Count = 1.4

ph-index = 3

Forward Citations = 27(Granted Patents)


Company Filing History:


Years Active: 2014-2022

Loading Chart...
Loading Chart...
Areas of Expertise:
Porous Material
Crystalline Form
Oxiracetam
Tissue Culture
Surgical Devices
Medical Implant
Drill Bit
Milling Cutter
23 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Lei Ye in Medical Technology**

Introduction

Lei Ye is a prominent inventor based in Chongqing, China, renowned for his innovative contributions to the field of medical technology. With an impressive portfolio of 23 patents, Lei has made significant strides toward advancing medical implants and pharmaceuticals, showcasing his commitment to enhancing human health.

Latest Patents

One of Lei Ye's notable inventions is a **porous material** designed for medical implants. This advanced hierarchical porous material features multilevel pore cavities that are carefully graded according to pore size. Its permeability surpasses 0.5×10 m, which ensures optimal blood flow, nutrient transmission, cell migration, and removal of cell fragments. This material significantly stimulates tissue growth and meets the critical requirements of human tissue regeneration.

Another groundbreaking invention from Lei is the **(R)-4-hydroxy-2-oxo-1-pyrrolidineacetamide** crystal form, which exhibits specific diffraction peaks essential for medical applications. This invention promotes the synthesis of phosphorylcholine and phosphoethanolamine while enhancing cerebral metabolism. It offers significant biological activity in fields such as sedation and anti-epileptic treatments. With a melting point of 133.1±2°C and a high solubility of over 100 mg/mL in water, this crystal form demonstrates excellent bioavailability and stability, making it suitable for various pharmaceutical compositions, including tablets and injections.

Career Highlights

Lei Ye has worked with notable companies such as Chongqing Runze Pharmaceutical Company Limited and Chongqing Ruzer Pharmaceutical Company Limited. His tenure in these companies has allowed him to forge innovative medical solutions and bring his ideas to life through practical applications of his research.

Collaborations

Throughout his career, Lei has collaborated with talented colleagues, including Hua Feng and Fei Li. His teamwork with these professionals highlights the importance of collaboration in driving innovation and achieving breakthroughs in medical technology.

Conclusion

With a remarkable array of patents and impactful inventions, Lei Ye exemplifies the spirit of innovation in medical technology. His work not only contributes to the advancement of medical materials but also significantly enhances the quality of patient care. The ongoing development of his ideas promises to yield further advancements that can transform the healthcare industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…